Bio-deactivation of anti-nutritional factors
01Overview and value chain
Markers: [EC: EU feed additive authorization (Regulation (EC) 1831/2003) | OECD: Food systems | Regulator: EFSA (EU), FDA (USA), MARA (China)]
Bio-deactivation of anti-nutritional factors (ANFs) applies enzymes and controlled fermentation to neutralize the phytic acid, trypsin inhibitors, β-conglycinin and oligosaccharides naturally present in soy, legume and cereal-based feed and food ingredients, which otherwise bind minerals and amino acids or interfere with digestion. In the EU, DSM-Firmenich received EU authorization on 24 September 2024 for HiPhorius, a next-generation phytase for all poultry species, Suidae (pigs and sows) and fin fish, achieving faster and more complete phytate degradation than earlier-generation phytases. Also in the EU, Denmark’s Hamlet Protein produces specialty fermented soy-based protein ingredients that hold ANF levels — trypsin inhibitors, β-conglycinin, galacto-oligosaccharides — consistently low batch to batch regardless of raw-material variability, and was acquired by Royal Agrifirm Group in a deal completed in May 2026. In China, Vland Biotech’s feed-grade phytase degrades phytate-bound phosphorus in plant-based feed ingredients, cutting livestock and poultry manure phosphorus excretion by 30–60% while releasing bound minerals, amino acids and trace elements for absorption. In the US, Novus International has published a decade-plus data review flagging trypsin inhibitors as a more significant, underappreciated risk in soy-based poultry and swine diets than previously recognized — even after conventional heat processing — and is pairing protease-enzyme supplementation with near-infrared (NIR) testing for more frequent raw-material screening.
The key directions of bio-deactivation of anti-nutritional factors are:
- Phytase-mediated phytate degradation (Phytase-Mediated Phytate Degradation): enzymes hydrolyzing phytic acid to release bound phosphorus, minerals and amino acids, cutting manure phosphorus and inorganic phosphate supplementation.
- Fermentation-based trypsin-inhibitor and oligosaccharide removal (Fermentation-Based Trypsin-Inhibitor and Oligosaccharide Removal): controlled microbial fermentation of soy/legume meal degrading protease inhibitors and oligosaccharides for young-animal digestibility.
- Protease-mediated trypsin-inhibitor neutralization (Protease-Mediated Trypsin-Inhibitor Neutralization): feed enzyme blends breaking down residual trypsin inhibitors that survive conventional heat processing.
- Rapid ANF quality screening (Rapid ANF Quality Screening): near-infrared and other rapid analytical technologies for real-time assessment of raw-material ANF variability, replacing infrequent lab testing.
Sectoral value chain
[raw material intake] ──> [ANF profiling/screening] ──> [bio-deactivation treatment] ──> [nutrient-release verification]
│
(digestibility/
phosphorus gain)
│
▼
[animal performance/sale] <─── [feed/ingredient formulation] <─────────────────┘Value chain levels
| Level | Description | Key inputs/outputs |
|---|---|---|
| Raw Material Intake | receiving soy, legume or cereal meal carrying naturally variable ANF content | In: raw plant-based feed/food ingredient. Out: batch pending ANF assessment. |
| ANF Profiling/Screening | rapidly assessing phytate, trypsin-inhibitor or oligosaccharide content of the incoming batch | In: raw batch, NIR/analytical testing. Out: batch-specific ANF profile. |
| Bio-Deactivation Treatment | applying phytase/protease enzymes or controlled fermentation to neutralize the profiled ANFs | In: ANF profile, enzyme/microbial culture. Out: ANF-reduced ingredient. |
| Nutrient-Release Verification | confirming the phosphorus, mineral or amino-acid release achieved by treatment | In: treated ingredient. Out: verified nutrient-release/digestibility metric. |
| Feed/Ingredient Formulation | incorporating the verified, ANF-reduced ingredient into a finished feed or food formulation | In: ANF-reduced ingredient. Out: finished feed/food formulation. |
| Animal Performance/Sale | measuring growth/digestibility outcomes and selling the finished, ANF-managed formulation | In: finished formulation. Out: growth performance data, product sale. |
Cross-cutting technologies of the sector:
- Microbial phytase enzymology (Microbial Phytase Enzymology): Aspergillus- and E. coli-derived phytases that hydrolyze phytic acid’s phosphate esters to release bound phosphorus and minerals.
- Controlled fermentation of legume meal (Controlled Fermentation of Legume Meal): defined fermentation processes degrading trypsin inhibitors, β-conglycinin and galacto-oligosaccharides in soy/legume ingredients.
- Rapid NIR-based ANF analytics (Rapid NIR-Based ANF Analytics): near-infrared testing enabling frequent, batch-level screening of raw-material ANF variability in place of infrequent lab assays.
02US
The US contributes an awareness and rapid-testing layer to ANF management, led by a feed-additive originator flagging a long-underestimated risk rather than a phytase-manufacturing base.
trypsin-inhibitor awareness research, NIR rapid-testing push, protease-based mitigation
- Novus International: published a decade-plus data review concluding trypsin inhibitors in soybean meal have a more significant impact on protein digestion and amino-acid availability than previously recognized, even after conventional heat processing, and is promoting protease-enzyme supplementation paired with near-infrared (NIR) testing for more frequent raw-material screening than traditional lab methods allow.
03CN
China anchors large-scale industrial phytase manufacturing aimed at cutting the phosphorus load that plant-based feed’s phytic acid content otherwise sends into livestock manure.
phytase-mediated phosphorus release, manure phosphorus reduction, listed industrial-enzyme scale
- Vland Biotech: produces a feed-grade phytase that degrades phytate-bound phosphorus in plant-based feed ingredients, releasing bound minerals, amino acids and trace elements for absorption while cutting livestock and poultry manure phosphorus excretion by 30–60%.
04EU
The EU anchors both next-generation phytase enzyme authorization and a distinct fermentation-based approach targeting non-phytate ANFs in soy, now consolidating under strategic (rather than private-equity) feed- industry ownership.
next-generation EU-authorized phytase, fermentation-based soy ANF removal, private-equity-to-strategic ownership shift
- DSM-Firmenich: received EU authorization on 24 September 2024 for HiPhorius, a next-generation phytase for all poultry species, Suidae and fin fish, achieving faster, more complete phytate degradation than earlier-generation phytases and reducing reliance on inorganic phosphorus supplements.
- Hamlet Protein: produces specialty fermented soy-based protein ingredients holding trypsin-inhibitor, β-conglycinin and galacto-oligosaccharide levels consistently low batch to batch for young-animal diets; acquired by Royal Agrifirm Group in a deal completed May 2026, moving from private-equity to strategic ownership within Agrifirm’s Specialties division.
05Leading companies and research institutes
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| DSM-Firmenich | 🇨🇭 Switzerland | HiPhorius next-generation phytase | EU-authorized 24 Sep 2024; poultry, Suidae, fin fish | Commercial |
| Hamlet Protein | 🇩🇰 Denmark | Fermented soy protein ingredients | consistently low ANFs (trypsin inhibitor, β-conglycinin, GOS) batch-to-batch | Commercial |
| Vland Biotech | 🇨🇳 China | Feed-grade phytase | −30 to −60% manure phosphorus excretion | Commercial |
| Novus International | 🇺🇸 USA | Trypsin-inhibitor testing & protease program | NIR rapid ANF screening + protease mitigation | Commercial |
06Tech stack and innovations
The stack pairs enzymatic and fermentation-based deactivation with rapid analytical screening.
- Phytase enzymology (Phytase Enzymology):
- microbial phytases hydrolyze phytic acid’s phosphate esters, releasing bound phosphorus, minerals and amino acids that would otherwise pass through the animal unabsorbed.
- case: DSM-Firmenich’s HiPhorius achieves faster, more complete phytate degradation than earlier-generation phytases, EU-authorized for poultry, pigs and fin fish.
- Fermentation-based ANF reduction (Fermentation-Based ANF Reduction):
- controlled microbial fermentation of soybean/legume meal degrades trypsin inhibitors, β-conglycinin and galacto-oligosaccharides that survive conventional heat processing.
- case: Hamlet Protein’s process holds ANF levels consistently low batch to batch regardless of raw-material variability.
- Rapid ANF analytics (Rapid ANF Analytics):
- near-infrared (NIR) and similar rapid-testing technologies screen incoming raw materials for ANF variability far more frequently than traditional lab assays allow.
- case: Novus International pairs protease supplementation with NIR testing to catch trypsin-inhibitor variability that traditional testing methods miss.
07Value chains and production pipelines
Industrial pipeline of enzymatic/fermentation ANF deactivation (EU Regulation (EC) 1831/2003 feed-additive framework)
┌───────────────────────────┐ ┌───────────────────────────┐
│ 1. Raw material intake │ ───> │ 2. ANF profiling/screening│
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 4. Nutrient-release verif.│ <─── │ 3. Bio-deactivation treat.│
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 5. Feed/ingredient formul.│ ───> │ 6. Animal performance/sale│
└───────────────────────────┘ └───────────────────────────┘Stage 1: Raw material intake
Soy, legume or cereal-based feed/food ingredient arrives carrying naturally variable levels of phytate, trypsin inhibitors or oligosaccharides.
Stage 2: ANF profiling/screening
Near-infrared or other rapid analytical testing assesses the batch’s specific ANF content, replacing infrequent traditional lab assays.
Stage 3: Bio-deactivation treatment
Phytase or protease enzymes, or a controlled fermentation process, are applied to neutralize the profiled anti-nutritional factors.
Stage 4: Nutrient-release verification
The phosphorus, mineral or amino-acid release achieved by the treatment is confirmed against the pre-treatment baseline.
Stage 5: Feed/ingredient formulation
The verified, ANF-reduced ingredient is incorporated into a finished feed or food formulation.
Stage 6: Animal performance/sale
Growth, digestibility and manure-phosphorus outcomes are measured, and the finished ANF-managed formulation is sold.
| Supplier | Price | Certificates | Risk | Confidence |
|---|---|---|---|---|
| DSM-Firmenich | on request | Low | MEDIUM | |
| Hamlet Protein | custom | Low | MEDIUM | |
| Vland Biotech | on request | Low | MEDIUM | |
| Novus International | on request | Medium | MEDIUM |
AI note: bio-deactivation-anti-nutritional-factors (EN)
Key directions:
- Phytase-mediated phytate degradation — enzymes releasing bound phosphorus, minerals and amino acids from phytic acid, cutting manure phosphorus and inorganic phosphate supplementation.
- Fermentation-based trypsin-inhibitor and oligosaccharide removal — controlled microbial fermentation of soy/legume meal for young-animal digestibility.
- Protease-mediated trypsin-inhibitor neutralization — feed enzyme blends breaking down residual inhibitors that survive conventional heat processing.
- Rapid ANF quality screening — near-infrared and similar rapid analytics replacing infrequent lab testing.
Regulatory:
- EU: DSM-Firmenich’s HiPhorius phytase went through the EU feed-additive authorization pathway (Regulation (EC) 1831/2003), granted 24 September 2024.
- China: MARA (Ministry of Agriculture and Rural Affairs) frames domestic feed-additive registration and the manure-phosphorus reduction policy driving phytase adoption.
Companies not in table: Alltech, Advanced Enzyme Technologies, Biomin and Sunson Industry Group were all investigated but excluded — Alltech’s and Advanced Enzyme Technologies’ returned sources were generic solid-state-fermentation/phytase academic papers with no attribution to the company’s own confirmed activity; Biomin’s sources were a mix of an unrelated competitor’s product page, a paywalled market report and generic broiler-trial literature; Sunson Industry Group’s Chinese-language sources were marketplace listings and an unrelated agricultural-university lecture announcement, not confirmed company activity. A first India candidate (Advanced Enzyme Technologies) and a second (Biomin) both failed re-verification within the cap-2-per-region rule, so the India/general section stays unconfirmed rather than forcing a third search round.
Processing note: this is a cold-start Industry (no INBOX dossier seed) built with deliberate awareness of a potential MECE collision — industrial-enzymes-biocatalysis already features AB Enzymes’ Monophyx/Zhutase phytase blend and cites Sunson/Angel Yeast as Chinese phytase producers via solid-state fermentation. This article was scoped to stay distinct by (a) using different flagship entities (DSM-Firmenich’s HiPhorius, Vland Biotech, rather than re-using AB Enzymes or Sunson as the lead phytase story) and (b) covering the non-phytate ANF mechanism (fermentation-based trypsin-inhibitor/oligosaccharide removal via Hamlet Protein, plus Novus International’s testing-and-awareness angle) that the sibling enzyme-industry article does not cover at all. Two entities used here (dsm-firmenich, novus-international, vland-biotech) already exist in the graph from other articles with different product lines (DSM’s HMO/vitamins/flavor lines, Novus’s MINTREX trace-mineral chelates, Vland’s broader industrial-enzyme/agri-microbial business) — reused legitimately here for a distinct, source-confirmed product angle (phytase/ANF), not duplicated as new entity stubs.
Relevance: this article’s four entries span the two genuinely distinct bio-deactivation mechanisms — enzymatic phytate hydrolysis (DSM-Firmenich’s newly EU-authorized HiPhorius, Vland Biotech’s high-volume Chinese manufacturing) versus fermentation-based removal of non-phytate ANFs (Hamlet Protein’s specialty soy line, recently absorbed into a major feed group via M&A) — plus a US entity (Novus International) contributing the awareness/testing layer rather than a product, illustrating that the industry’s frontier is as much about detecting ANF variability as neutralizing it.